reference/24814350

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24814350

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Research Support, N.I.H., Intramural
endingPage	317
issn	1097-0142 0008-543X
issueIdentifier	2
pageRange	309-317
publicationName	Cancer
startingPage	309
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_969ccf6fe026f2f48265f62ea5c814c6
bibliographicCitation	Posadas EM, Kwitkowski V, Kotz HL, Espina V, Minasian L, Tchabo N, Premkumar A, Hussain MM, Chang R, Steinberg SM, Kohn EC. A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling. Cancer. 2007 Jul 15;110(2):309–17. doi: 10.1002/cncr.22757. PMID: 17559139.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c328789958cbfac8660c9e10663bcfe8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ff26af37e1eadfbdb296b1ae8934333 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_383b81e3614f2183c4ea18bf16841682 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da40b6ca0299eed249a490c12f72d3ad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bd90f62f3912af9e3dffaa08a51fc24 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35ec2d067be9329b3fe7576da6c0cf66 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55e5c24b27bf32263c734585a11bf97d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f81162a9df860b2c99bb54fad4bb391 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1faf5e6a3219e1b5d98c8cc510b58524 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5325445c4469591f73f07af182401b18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_605550b4a05fc8a2e5fb7a56394bef78
date	2007-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/17559139 https://doi.org/10.1002/cncr.22757
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771 https://portal.issn.org/resource/ISSN/0008-543X https://portal.issn.org/resource/ISSN/1097-0142
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling
discusses	http://id.nlm.nih.gov/mesh/M0028387 http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0328053 http://id.nlm.nih.gov/mesh/M0024747 http://id.nlm.nih.gov/mesh/M0018260
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D019009Q000378 http://id.nlm.nih.gov/mesh/D010879Q000627 http://id.nlm.nih.gov/mesh/D010051Q000188 http://id.nlm.nih.gov/mesh/D020543 http://id.nlm.nih.gov/mesh/D000970Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D001201 http://id.nlm.nih.gov/mesh/D016207Q000097 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D010879Q000009 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D010051Q000378 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D011743Q000009 http://id.nlm.nih.gov/mesh/D000068877
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ffa044f5d18974a3264c23a5e1e06217 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7548 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6977 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6653 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5bf20507b757dd624886dac9baef5c7d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8900 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7947

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3815 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368395 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595

Total number of triples: 79.